IBDEI1K3 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25229,0)
 ;;=96164^^91^1144^4^^^^1
 ;;^UTILITY(U,$J,358.3,25229,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25229,1,2,0)
 ;;=2^96164
 ;;^UTILITY(U,$J,358.3,25229,1,3,0)
 ;;=3^Hlth/Behav Interv,Grp,Init 30 min
 ;;^UTILITY(U,$J,358.3,25230,0)
 ;;=96165^^91^1144^5^^^^1
 ;;^UTILITY(U,$J,358.3,25230,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25230,1,2,0)
 ;;=2^96165
 ;;^UTILITY(U,$J,358.3,25230,1,3,0)
 ;;=3^Hlth/Behav Interv,Grp,Ea Addl 15 min
 ;;^UTILITY(U,$J,358.3,25231,0)
 ;;=90471^^91^1145^1^^^^1
 ;;^UTILITY(U,$J,358.3,25231,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25231,1,2,0)
 ;;=2^90471
 ;;^UTILITY(U,$J,358.3,25231,1,3,0)
 ;;=3^IMMUNIZATION ADMIN,1 INJECTION
 ;;^UTILITY(U,$J,358.3,25232,0)
 ;;=90472^^91^1145^2^^^^1
 ;;^UTILITY(U,$J,358.3,25232,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25232,1,2,0)
 ;;=2^90472
 ;;^UTILITY(U,$J,358.3,25232,1,3,0)
 ;;=3^IMMUN ADMIN, EACH ADDITIONAL
 ;;^UTILITY(U,$J,358.3,25233,0)
 ;;=90732^^91^1146^30^^^^1
 ;;^UTILITY(U,$J,358.3,25233,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25233,1,2,0)
 ;;=2^90732
 ;;^UTILITY(U,$J,358.3,25233,1,3,0)
 ;;=3^PNEUMOVAX 23 (PNEUMOCOCCAL VACCINE)
 ;;^UTILITY(U,$J,358.3,25234,0)
 ;;=90658^^91^1146^12^^^^1
 ;;^UTILITY(U,$J,358.3,25234,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25234,1,2,0)
 ;;=2^90658
 ;;^UTILITY(U,$J,358.3,25234,1,3,0)
 ;;=3^FLU VACCINE MULTI DOSE VIAL (AFLURIA IIV3)
 ;;^UTILITY(U,$J,358.3,25235,0)
 ;;=90585^^91^1146^1^^^^1
 ;;^UTILITY(U,$J,358.3,25235,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25235,1,2,0)
 ;;=2^90585
 ;;^UTILITY(U,$J,358.3,25235,1,3,0)
 ;;=3^BCG VACCINE, PERCUT
 ;;^UTILITY(U,$J,358.3,25236,0)
 ;;=90632^^91^1146^17^^^^1
 ;;^UTILITY(U,$J,358.3,25236,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25236,1,2,0)
 ;;=2^90632
 ;;^UTILITY(U,$J,358.3,25236,1,3,0)
 ;;=3^HEP A VACCINE, ADULT IM
 ;;^UTILITY(U,$J,358.3,25237,0)
 ;;=90636^^91^1146^18^^^^1
 ;;^UTILITY(U,$J,358.3,25237,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25237,1,2,0)
 ;;=2^90636
 ;;^UTILITY(U,$J,358.3,25237,1,3,0)
 ;;=3^HEP A/HEP B VACC, ADULT IM
 ;;^UTILITY(U,$J,358.3,25238,0)
 ;;=90647^^91^1146^22^^^^1
 ;;^UTILITY(U,$J,358.3,25238,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25238,1,2,0)
 ;;=2^90647
 ;;^UTILITY(U,$J,358.3,25238,1,3,0)
 ;;=3^HIB VACCINE, PRP-OMP, IM
 ;;^UTILITY(U,$J,358.3,25239,0)
 ;;=90648^^91^1146^23^^^^1
 ;;^UTILITY(U,$J,358.3,25239,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25239,1,2,0)
 ;;=2^90648
 ;;^UTILITY(U,$J,358.3,25239,1,3,0)
 ;;=3^HIB VACCINE, PRP-T, IM
 ;;^UTILITY(U,$J,358.3,25240,0)
 ;;=90649^^91^1146^16^^^^1
 ;;^UTILITY(U,$J,358.3,25240,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25240,1,2,0)
 ;;=2^90649
 ;;^UTILITY(U,$J,358.3,25240,1,3,0)
 ;;=3^H PAPILLOMA VACC 3 DOSE IM
 ;;^UTILITY(U,$J,358.3,25241,0)
 ;;=90675^^91^1146^34^^^^1
 ;;^UTILITY(U,$J,358.3,25241,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25241,1,2,0)
 ;;=2^90675
 ;;^UTILITY(U,$J,358.3,25241,1,3,0)
 ;;=3^RABIES VACCINE, IM
 ;;^UTILITY(U,$J,358.3,25242,0)
 ;;=90676^^91^1146^33^^^^1
 ;;^UTILITY(U,$J,358.3,25242,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25242,1,2,0)
 ;;=2^90676
 ;;^UTILITY(U,$J,358.3,25242,1,3,0)
 ;;=3^RABIES VACCINE, ID
 ;;^UTILITY(U,$J,358.3,25243,0)
 ;;=90680^^91^1146^35^^^^1
 ;;^UTILITY(U,$J,358.3,25243,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,25243,1,2,0)
 ;;=2^90680
 ;;^UTILITY(U,$J,358.3,25243,1,3,0)
 ;;=3^ROTOVIRUS VACC 3 DOSE, ORAL
